Manufacturer record
Pentachem Pharmaceutical: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Pentachem Pharmaceutical (Himachal Pradesh) were declared Not of Standard Quality between December 2023 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PCGT-25013, Diclofenac Potassium & Pracetamol Tablets (exp Dec 2026). DTL, Jaipur (state lab) found it not of standard quality: The sample does not conform to the claim with respect to Assay. Listed in the December 2025 alert.
Records by type
2 records linked to Pentachem Pharmaceutical in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Potassium & Pracetamol Tablets | Batch PCGT-25013Mfg Jan 2025 · Exp Dec 2026 | The sample does not conform to the claim with respect to AssayAssay | DTL, JaipurState lab | Dec 2025 |
| ISONIAZID TABLETS IP 300 MG (ISONIAZID-300) | Batch PT23-108Mfg May 2023 · Exp Apr 2025 | DescriptionDescription | RDTL GuwahatiState lab | Dec 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.